Trial intelligence / Profile preview

Oncothermia with Chemotherapy in Metastatic Pancreatic Cancer

NCT02862015Phase 2Unknown

Sponsor
Seoul National University Hospital
Start
Aug 2016
Primary completion
Jul 2019
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ)-C30 score change at 3 months. Status: unknown.

Beyond the preview

Go deeper on NCT02862015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02862015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call